UNAIDS

8.

New report by Kaiser and UNAIDS shows 2017 spike in global funding for HIV

31 Jul 2018
Apparent ‘boost’ due to shift in timing of U.S. disbursements, study finds

Donor government disbursements to combat HIV in low- and middle-income countries increased 16 percent from US$7 billion in 2016 to US$8.1 billion in 2017 – though the higher total stems largely from the timing of U.S.

6.

Global Fund multi-country program in East Africa spearheads trip to China to learn about harm reduction technologies

30 Jul 2018
Government officials and Global Fund implementers from Kenya, Tanzania, and Uganda traveled to China to learn about local innovations in methadone maintenance therapy

As part of an official delegation spearheaded by Kenya-based KANCO and co-sponsored by UNAIDS, the UN Office on Drugs and Crime (UNODC), and the International HIV/AIDS Alliance, twenty-two representatives of East African governments

3.

“A Quarter for Prevention”: Study finds Global Fund investments in HIV prevention in Africa fall short

27 Jun 2017
Across 15 countries, just 15% of grant programs from the 2014-2016 funding cycle went towards HIV prevention

A new discussion paper released by ICASO and EANNASO suggests that the Global Fund might not be investing enough money in HIV prevention in Africa to meet its targets.

5.

Communities report reduced support from the Global Fund and other donors

30 May 2017
Growing economy does not mean growing domestic support for communities

“There is a painful awareness among communities in countries whose economies are growing that donors are pulling out and abandoning them… This [transitioning] process is driven by the criteria donors have laid out for eligibility, and demonstrated by the actual level of disbursements going to some countries. But communities know that growing economies do not equal growing domestic support for communities in the HIV response.”

3.

Global Fund pushes back on claims of overdependence on select suppliers of ARVs

17 Apr 2017
Buyers had been warned to diversify the manufacturing base or risk supply interruptions

The Global Fund, one of the main purchasers of generic antiretroviral (ARV) medicines for HIV patients in low- and middle-income countries, has dismissed concerns that the limited number of manufacturers tapped to supply these drugs could result in immediate or future shortages. Fund officials said systems are in place to forecast demand, deal with any supply disruptions and increase production to meet future need.

2.

After initially rejecting a plea for assistance from Venezuelan NGOs out of hand, the Global Fund now says it may be able to help

14 Feb 2017
The Fund says it will try to provide assistance through other agencies

In an exchange of letters that spanned more than seven months, the Global Fund at first rejected a plea for help from the Venezuelan Network of Positive People (RVG+), but then may have left the door open to providing some assistance via other agencies. This is a story that is still unfolding.

According to the Global Fund, Venezuela is currently not eligible for funding under the Fund’s Eligibility Policy.

5.

HIV prevention advocates push Global Fund for more expenditure data

12 Feb 2017
In bid to improve lobbying efforts, activists look for more information on how much money goes to prevention activities

The Global Fund has pledged to re-energize HIV prevention and, in line with that commitment, civil society groups are calling on the Fund to offer more explicit data on how much it spends on these efforts. That includes not only overall expenditure data, but also granular information, like spending at a country level and spending on specific interventions.

4.

AHF and researchers call for more transparency in UNAIDS’ estimates of the numbers of people on ARVs

17 Sep 2016
The Global Burden of Disease 2015 Study produced some results that differ from the UNAIDS’ figures
UNAIDS responds that it is confident its estimates are accurate

The AIDS Healthcare Foundation (AHF), a Los Angeles-based AIDS service and activist organization with a global reach, has called for more transparency and accountability in the way UNAIDS estimates the number of people living with HIV/AIDS who are on life-saving antiretroviral treatment.

3.

GFAN report describes “The Cost of Inaction”

2 Aug 2016
Key populations will suffer the most if the Global Fund’s replenishment target is not met
1.

At Financing for Development conference, the outlines of a plan to fund the post-2015 development agenda

17 Jul 2015
Outcomes of meeting should offer insight into donor postures ahead of Global Fund’s own replenishment campaign in mid-2016

A high-level meeting of global stakeholders took place 13-16 July in Addis Ababa to develop a strategy to finance the post-2015 sustainable development goals, against a backdrop of donor fatigue, the enduring global financial crisis and a growing insistence on improved domestic financing for development issues.

Pages

Subscribe to UNAIDS